Cargando…
Phages Needed against Resistant Bacteria
Phages have been known for more than 100 years. They have been applied to numerous infectious diseases and have proved to be effective in many cases. However, they have been neglected due to the era of antibiotics. With the increase of antibiotic-resistant microorganisms, we need additional therapie...
Autor principal: | |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7412541/ https://www.ncbi.nlm.nih.gov/pubmed/32664292 http://dx.doi.org/10.3390/v12070743 |
_version_ | 1783568631975641088 |
---|---|
author | Moelling, Karin |
author_facet | Moelling, Karin |
author_sort | Moelling, Karin |
collection | PubMed |
description | Phages have been known for more than 100 years. They have been applied to numerous infectious diseases and have proved to be effective in many cases. However, they have been neglected due to the era of antibiotics. With the increase of antibiotic-resistant microorganisms, we need additional therapies. Whether or not phages can fulfill this expectation needs to be verified and tested according to the state-of-the-art of international regulations. These regulations fail, however, with respect to GMP production of phages. Phages are biologicals, not chemical compounds, which cannot be produced under GMP regulations. This needs to be urgently changed to allow progress to determine how phages can enter routine clinical settings. |
format | Online Article Text |
id | pubmed-7412541 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-74125412020-08-26 Phages Needed against Resistant Bacteria Moelling, Karin Viruses Commentary Phages have been known for more than 100 years. They have been applied to numerous infectious diseases and have proved to be effective in many cases. However, they have been neglected due to the era of antibiotics. With the increase of antibiotic-resistant microorganisms, we need additional therapies. Whether or not phages can fulfill this expectation needs to be verified and tested according to the state-of-the-art of international regulations. These regulations fail, however, with respect to GMP production of phages. Phages are biologicals, not chemical compounds, which cannot be produced under GMP regulations. This needs to be urgently changed to allow progress to determine how phages can enter routine clinical settings. MDPI 2020-07-10 /pmc/articles/PMC7412541/ /pubmed/32664292 http://dx.doi.org/10.3390/v12070743 Text en © 2020 by the author. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Commentary Moelling, Karin Phages Needed against Resistant Bacteria |
title | Phages Needed against Resistant Bacteria |
title_full | Phages Needed against Resistant Bacteria |
title_fullStr | Phages Needed against Resistant Bacteria |
title_full_unstemmed | Phages Needed against Resistant Bacteria |
title_short | Phages Needed against Resistant Bacteria |
title_sort | phages needed against resistant bacteria |
topic | Commentary |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7412541/ https://www.ncbi.nlm.nih.gov/pubmed/32664292 http://dx.doi.org/10.3390/v12070743 |
work_keys_str_mv | AT moellingkarin phagesneededagainstresistantbacteria |